FDA Releases Draft Guidance on Civil Money Penalties for ClinicalTrials.gov Violations

Summary

The Food and Drug Administration (FDA) has released a draft guidance outlining the agency's approach to assessing civil money penalties for companies and individuals that fail to comply with regulations related to clinical trials, including those registered on ClinicalTrials.gov.